Home 2014

Archives

Healthcare immunization: Protecting coworkers and the community

Health care professionals are at high risk for exposure to vaccine-preventable diseases and infections. Safeguard yourself, your patients, and your family members. Make sure...

FDA approves new product to treat hereditary angioedema

On July 16, the U.S. Food and Drug Administration (FDA) approved Ruconest, the first recombinant C1-Esterase Inhibitor product for the treatment of acute attacks...

FDA approves new indication for imaging agent

On June 13, the U.S. Food and Drug Administration (FDA) a new use for Lymphoseek (technetium 99m tilmanocept) Injection, a radioactive diagnostic imaging agent...

FDA approves Impavido to treat leishmaniasis

On March 19, the U.S. Food and Drug Administration (FDA) approved Impavido (miltefosine) to treat a tropical disease called leishmaniasis. Read more.

New intravaginal ring

Researchers have developed a new intravaginal ring for the sustained 90-day co-delivery of tenofovir and levonorgestrel, an anti-human immunodeficiency virus (HIV) drug and a...

Chemotherapy and Biotherapy Drugs for Autoimmune Disease

New biotherapy drugs and older chemotherapy agents may improve quality of life in patients with autoimmune diseases.

Updated guidelines for managing occupational HIV exposure released

Infection Control and Epidemiology has published “Updated US Public Health Service guidelines for the management of occupational exposures to human immunodeficiency virus and recommendations...

Study: Poor sleep in pregnancy may contribute to birth-related complications

Poor sleep quality and quantity during pregnancy can disrupt normal immune processes and may lead to lower birth weights and other complications, according to...

Be prepared for poison ivy, oak, and sumac

The author clears up misconceptions and discusses treatment.

Soothing the sorrow of psoriasis

You can help patients suffering from this chronic skin disease.

FDA approves first anti-diarrheal drug for HIV/AIDS patients

On Dec. 31, 2012, the U.S. Food and Drug Administration (FDA) approved Fulyzaq (crofelemer) to relieve symptoms of diarrhea in HIV/AIDS patients taking antiretroviral...

FDA approves Xeljanz for rheumatoid arthritis

On Nov. 6, the U.S. Food and Drug Administration (FDA) approved Xeljanz (tofacitinib) to treat adults with moderately to severely active rheumatoid arthritis who...

FDA approves new MS drug

On Sept. 12, the U.S. Food and Drug Administration (FDA) approved Aubagio (teriflunomide), a once-a-day tablet for the treatment of adults with relapsing forms...